Keyword → UnitedHealth stock

UnitedHealth Q2 2026 EPS Hits $6.38, Beats by $1.46 — Full-Year Guidance Raised to $19.50–$20.00 as Medical Ratio Falls to 86.7%

UnitedHealth Group reported Q2 2026 adjusted EPS of $6.38, crushing the $4.90 consensus by $1.46, as revenue reached $112.03 billion versus $110.85 billion expected. The medical benefit ratio improved sharply to 86.7% from 89.4% a year ago. Full-year adjusted EPS guidance was raised to $19.50–$20.00, well above the prior outlook of greater than $18.25. Cash flow guidance was lifted to $24 billion. Shares jumped roughly 7% premarket, outperforming a broadly declining tape.